DISASSOCIATION BETWEEN DEBRISOQUINE HYDROXYLATION PHENOTYPE AND GENOTYPE AMONG CHINESE
- 1 October 1989
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 334 (8667) , 870
- https://doi.org/10.1016/s0140-6736(89)93041-9
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.British Journal of Clinical Pharmacology, 1989
- Polymorphic debrisoquin hydroxylation in 757 Swedish subjectsClinical Pharmacology & Therapeutics, 1988
- Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs.Proceedings of the National Academy of Sciences, 1988
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980